We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.84%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
FAF
251
Fjarde Ap-fonden
Sweden
$16.2M +$8.06M +36,005 +116%
CWG
252
C WorldWide Group
Denmark
$15.9M +$14.8M +66,022 New
TGHSA
253
TPG Group Holdings (SBS) Advisors
Texas
$15.8M +$7.01M +31,330 +92%
IRF
254
IBM Retirement Fund
New York
$15.7M +$4.6M +20,538 +46%
EIM
255
ExxonMobil Investment Management
Texas
$15.6M +$4.31M +19,266 +42%
OPERF
256
Oregon Public Employees Retirement Fund
Oregon
$15.6M +$5.51M +24,625 +61%
AIA
257
Affinity Investment Advisors
California
$15.3M -$2.28M -10,178 -14%
Group One Trading
258
Group One Trading
Illinois
$15.3M +$10.8M +48,223 +319%
ST
259
Spot Trading
Illinois
$15.2M +$9.86M +44,052 +233%
JCM
260
Janney Capital Management
Pennsylvania
$15.1M +$14M +62,645 New
PCM
261
Pentwater Capital Management
Florida
$15.1M +$14M +62,500 New
ZIM
262
Zacks Investment Management
Illinois
$14.8M -$655K -2,929 -5%
KCM
263
Kingdon Capital Management
New York
$14.8M +$2.59M +11,569 +23%
BPB
264
Badgley, Phelps & Bell
Washington
$14.8M +$543K +2,427 +4%
Fifth Third Bancorp
265
Fifth Third Bancorp
Ohio
$14.7M +$11.4M +50,948 +501%
WG
266
Winton Group
United Kingdom
$14.7M -$15.8M -70,796 -54%
AIA
267
Avalon Investment & Advisory
Texas
$14.6M +$377K +1,684 +3%
DekaBank Deutsche Girozentrale
268
DekaBank Deutsche Girozentrale
Germany
$14.5M +$4.4M +19,642 +49%
JMH
269
J.M. Hartwell
New York
$14.1M -$1.9M -8,470 -13%
GI
270
GAMCO Investors
Connecticut
$14M +$4.9M +21,891 +61%
TEC
271
Tiger Eye Capital
Tennessee
$13.9M -$16.8M -75,200 -57%
PWPCM
272
Perella Weinberg Partners Capital Management
New York
$13.9M +$138K +616 +1%
Connor, Clark & Lunn Investment Management (CC&L)
273
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$13.5M +$2.75M +12,300 +28%
PA
274
Pinnacle Associates
New York
$13.3M +$12.3M +55,001 New
AIM
275
Allen Investment Management
New York
$13.3M +$12.3M +55,000 New

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.